{"transactions":[{"id":4639702,"issuer":{"id":8251,"kind":"organization","name":"Cadrenal Therapeutics, Inc.","symbol":"CVKD"},"owners":[{"id":33911,"kind":"person","name":"Pham Quang X","position":1,"cik":"0001405290","reported_name":"Pham Quang X","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Stock Option","published_at":"2026-10-13T21:33:28.000Z","date":"2026-10-09","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The stock options have a grant date of October 9, 2026 under the Issuer's 2022 Successor Equity Incentive Plan, were fully vested and immediately exercisable on the date of grant, and have an exercise price equal to the closing price of the Issuer's common stock on October 9, 2026."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options have a grant date of October 9, 2026 under the Issuer's 2022 Successor Equity Incentive Plan, were fully vested and immediately exercisable on the date of grant, and have an exercise price equal to the closing price of the Issuer's common stock on October 9, 2026."}],"balance_after":200000,"derivative":{"exercise_price":0.91,"exercise_date":"2026-10-09","expiration_date":"2036-10-08","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001213900-26-109132","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1937993/000121390026109132/ownership.xml","form_type":"4"}},{"id":720990,"issuer":{"id":8251,"kind":"organization","name":"Cadrenal Therapeutics, Inc.","symbol":"CVKD"},"owners":[{"id":33911,"kind":"person","name":"Pham Quang X","position":1,"cik":"0001405290","reported_name":"Pham Quang X","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman and CEO"}}],"security":"Common Stock","published_at":"2026-07-02T01:52:04.000Z","date":"2026-06-29","kind":"sale","planned":true,"acquired":false,"shares":7400,"price":3.03,"value":22422.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of the Issuer's common stock sold by the Reporting Person in accordance with a Rule 10b5-1 trading arrangement adopted by the Reporting Person on September 25, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.00 through $3.13. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":98589,"source":{"system":"sec-edgar","filing":"0001213900-26-074557","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1405290/000121390026074557/ownership.xml","form_type":"4"}},{"id":725398,"issuer":{"id":8251,"kind":"organization","name":"Cadrenal Therapeutics, Inc.","symbol":"CVKD"},"owners":[{"id":33911,"kind":"person","name":"Pham Quang X","position":1,"cik":"0001405290","reported_name":"Pham Quang X","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman, CEO and Interim CFO"}}],"security":"Common Stock","published_at":"2026-06-27T00:44:47.000Z","date":"2026-06-26","kind":"sale","planned":true,"acquired":false,"shares":9029,"price":3.05,"value":27538.45,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of the Issuer's common stock sold by the Reporting Person in accordance with a Rule 10b5-1 trading arrangement adopted by the Reporting Person on September 25, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.00 through $3.18. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":105989,"source":{"system":"sec-edgar","filing":"0001213900-26-072789","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1405290/000121390026072789/ownership.xml","form_type":"4"}},{"id":725397,"issuer":{"id":8251,"kind":"organization","name":"Cadrenal Therapeutics, Inc.","symbol":"CVKD"},"owners":[{"id":33911,"kind":"person","name":"Pham Quang X","position":1,"cik":"0001405290","reported_name":"Pham Quang X","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman, CEO and Interim CFO"}}],"security":"Common Stock","published_at":"2026-06-27T00:44:47.000Z","date":"2026-06-25","kind":"sale","planned":true,"acquired":false,"shares":2127,"price":3,"value":6381.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of the Issuer's common stock sold by the Reporting Person in accordance with a Rule 10b5-1 trading arrangement adopted by the Reporting Person on September 25, 2025."}],"balance_after":115018,"source":{"system":"sec-edgar","filing":"0001213900-26-072789","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1405290/000121390026072789/ownership.xml","form_type":"4"}},{"id":727521,"issuer":{"id":8251,"kind":"organization","name":"Cadrenal Therapeutics, Inc.","symbol":"CVKD"},"owners":[{"id":33911,"kind":"person","name":"Pham Quang X","position":1,"cik":"0001405290","reported_name":"Pham Quang X","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman, CEO and Interim CFO"}}],"security":"Common Stock","published_at":"2026-06-24T21:15:13.000Z","date":"2026-06-23","kind":"sale","planned":true,"acquired":false,"shares":2277,"price":3.2,"value":7286.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of the Issuer's common stock sold by the Reporting Person in accordance with a Rule 10b5-1 trading arrangement adopted by the Reporting Person on September 25, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.20 through $3.22. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":117145,"source":{"system":"sec-edgar","filing":"0001213900-26-071578","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1405290/000121390026071578/ownership.xml","form_type":"4"}},{"id":727520,"issuer":{"id":8251,"kind":"organization","name":"Cadrenal Therapeutics, Inc.","symbol":"CVKD"},"owners":[{"id":33911,"kind":"person","name":"Pham Quang X","position":1,"cik":"0001405290","reported_name":"Pham Quang X","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman, CEO and Interim CFO"}}],"security":"Common Stock","published_at":"2026-06-24T21:15:13.000Z","date":"2026-06-22","kind":"sale","planned":true,"acquired":false,"shares":9167,"price":3.55,"value":32542.85,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of the Issuer's common stock sold by the Reporting Person in accordance with a Rule 10b5-1 trading arrangement adopted by the Reporting Person on September 25, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.51 through $3.62. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":119422,"source":{"system":"sec-edgar","filing":"0001213900-26-071578","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1405290/000121390026071578/ownership.xml","form_type":"4"}},{"id":731885,"issuer":{"id":8251,"kind":"organization","name":"Cadrenal Therapeutics, Inc.","symbol":"CVKD"},"owners":[{"id":33911,"kind":"person","name":"Pham Quang X","position":1,"cik":"0001405290","reported_name":"Pham Quang X","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman, CEO and Interim CFO"}}],"security":"Common Stock","published_at":"2026-06-18T22:36:46.000Z","date":"2026-06-17","kind":"sale","planned":true,"acquired":false,"shares":513,"price":3.16,"value":1621.08,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of the Issuer's common stock sold by the Reporting Person in accordance with a Rule 10b5-1 trading arrangement adopted by the Reporting Person on September 25, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.14 through $3.20. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":128589,"source":{"system":"sec-edgar","filing":"0001213900-26-070248","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1405290/000121390026070248/ownership.xml","form_type":"4"}},{"id":731884,"issuer":{"id":8251,"kind":"organization","name":"Cadrenal Therapeutics, Inc.","symbol":"CVKD"},"owners":[{"id":33911,"kind":"person","name":"Pham Quang X","position":1,"cik":"0001405290","reported_name":"Pham Quang X","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman, CEO and Interim CFO"}}],"security":"Common Stock","published_at":"2026-06-18T22:36:46.000Z","date":"2026-06-16","kind":"sale","planned":true,"acquired":false,"shares":3613,"price":3.18,"value":11489.34,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of the Issuer's common stock sold by the Reporting Person in accordance with a Rule 10b5-1 trading arrangement adopted by the Reporting Person on September 25, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.04 through $3.37. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":129102,"source":{"system":"sec-edgar","filing":"0001213900-26-070248","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1405290/000121390026070248/ownership.xml","form_type":"4"}},{"id":737670,"issuer":{"id":8251,"kind":"organization","name":"Cadrenal Therapeutics, Inc.","symbol":"CVKD"},"owners":[{"id":33911,"kind":"person","name":"Pham Quang X","position":1,"cik":"0001405290","reported_name":"Pham Quang X","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman, CEO and Interim CFO"}}],"security":"Common Stock","published_at":"2026-06-16T00:58:15.000Z","date":"2026-06-15","kind":"sale","planned":false,"acquired":false,"shares":3666,"price":3.58,"value":13124.28,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of the Issuer's common stock sold by the Reporting Person in accordance with a Rule 10b5-1 trading arrangement adopted by the Reporting Person on September 25, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.22 through $3.81. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":132715,"source":{"system":"sec-edgar","filing":"0001213900-26-068981","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1405290/000121390026068981/ownership.xml","form_type":"4"}},{"id":737669,"issuer":{"id":8251,"kind":"organization","name":"Cadrenal Therapeutics, Inc.","symbol":"CVKD"},"owners":[{"id":33911,"kind":"person","name":"Pham Quang X","position":1,"cik":"0001405290","reported_name":"Pham Quang X","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman, CEO and Interim CFO"}}],"security":"Common Stock","published_at":"2026-06-16T00:58:15.000Z","date":"2026-06-12","kind":"sale","planned":false,"acquired":false,"shares":12996,"price":3.94,"value":51204.24,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of the Issuer's common stock sold by the Reporting Person in accordance with a Rule 10b5-1 trading arrangement adopted by the Reporting Person on September 25, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.80 through $4.23. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":136381,"source":{"system":"sec-edgar","filing":"0001213900-26-068981","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1405290/000121390026068981/ownership.xml","form_type":"4"}},{"id":737668,"issuer":{"id":8251,"kind":"organization","name":"Cadrenal Therapeutics, Inc.","symbol":"CVKD"},"owners":[{"id":33911,"kind":"person","name":"Pham Quang X","position":1,"cik":"0001405290","reported_name":"Pham Quang X","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman, CEO and Interim CFO"}}],"security":"Common Stock","published_at":"2026-06-16T00:58:15.000Z","date":"2026-06-11","kind":"sale","planned":false,"acquired":false,"shares":1462,"price":4.12,"value":6023.44,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of the Issuer's common stock sold by the Reporting Person in accordance with a Rule 10b5-1 trading arrangement adopted by the Reporting Person on September 25, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.09 through $4.16. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":149377,"source":{"system":"sec-edgar","filing":"0001213900-26-068981","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1405290/000121390026068981/ownership.xml","form_type":"4"}},{"id":742980,"issuer":{"id":8251,"kind":"organization","name":"Cadrenal Therapeutics, Inc.","symbol":"CVKD"},"owners":[{"id":33911,"kind":"person","name":"Pham Quang X","position":1,"cik":"0001405290","reported_name":"Pham Quang X","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman, CEO and Interim CFO"}}],"security":"Common Stock","published_at":"2026-06-11T00:26:15.000Z","date":"2026-06-10","kind":"sale","planned":true,"acquired":false,"shares":3500,"price":4.21,"value":14735.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of the Issuer's common stock sold by the Reporting Person in accordance with a Rule 10b5-1 trading arrangement adopted by the Reporting Person on September 25, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.20 through $4.23. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":150839,"source":{"system":"sec-edgar","filing":"0001213900-26-067484","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1405290/000121390026067484/ownership.xml","form_type":"4"}},{"id":742979,"issuer":{"id":8251,"kind":"organization","name":"Cadrenal Therapeutics, Inc.","symbol":"CVKD"},"owners":[{"id":33911,"kind":"person","name":"Pham Quang X","position":1,"cik":"0001405290","reported_name":"Pham Quang X","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman, CEO and Interim CFO"}}],"security":"Common Stock","published_at":"2026-06-11T00:26:15.000Z","date":"2026-06-09","kind":"sale","planned":true,"acquired":false,"shares":12992,"price":4.06,"value":52747.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of the Issuer's common stock sold by the Reporting Person in accordance with a Rule 10b5-1 trading arrangement adopted by the Reporting Person on September 25, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.03 through $4.34. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":154339,"source":{"system":"sec-edgar","filing":"0001213900-26-067484","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1405290/000121390026067484/ownership.xml","form_type":"4"}},{"id":742978,"issuer":{"id":8251,"kind":"organization","name":"Cadrenal Therapeutics, Inc.","symbol":"CVKD"},"owners":[{"id":33911,"kind":"person","name":"Pham Quang X","position":1,"cik":"0001405290","reported_name":"Pham Quang X","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chairman, CEO and Interim CFO"}}],"security":"Common Stock","published_at":"2026-06-11T00:26:15.000Z","date":"2026-06-08","kind":"sale","planned":true,"acquired":false,"shares":5893,"price":4.38,"value":25811.34,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of the Issuer's common stock sold by the Reporting Person in accordance with a Rule 10b5-1 trading arrangement adopted by the Reporting Person on September 25, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.20 through $4.51. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":167331,"source":{"system":"sec-edgar","filing":"0001213900-26-067484","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1405290/000121390026067484/ownership.xml","form_type":"4"}},{"id":747772,"issuer":{"id":8251,"kind":"organization","name":"Cadrenal Therapeutics, Inc.","symbol":"CVKD"},"owners":[{"id":33911,"kind":"person","name":"Pham Quang X","position":1,"cik":"0001405290","reported_name":"Pham Quang X","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2026-06-05T21:26:24.000Z","date":"2026-06-05","kind":"sale","planned":true,"acquired":false,"shares":2064,"price":4.42,"value":9122.88,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of the Issuer's common stock sold by the Reporting Person in accordance with a Rule 10b5-1 trading arrangement adopted by the Reporting Person on September 25, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.25 through $4.50. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":173224,"source":{"system":"sec-edgar","filing":"0001213900-26-065925","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1405290/000121390026065925/ownership.xml","form_type":"4"}},{"id":747771,"issuer":{"id":8251,"kind":"organization","name":"Cadrenal Therapeutics, Inc.","symbol":"CVKD"},"owners":[{"id":33911,"kind":"person","name":"Pham Quang X","position":1,"cik":"0001405290","reported_name":"Pham Quang X","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2026-06-05T21:26:24.000Z","date":"2026-06-04","kind":"sale","planned":true,"acquired":false,"shares":3898,"price":4.41,"value":17190.18,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of the Issuer's common stock sold by the Reporting Person in accordance with a Rule 10b5-1 trading arrangement adopted by the Reporting Person on September 25, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.19 through $4.47. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":175288,"source":{"system":"sec-edgar","filing":"0001213900-26-065925","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1405290/000121390026065925/ownership.xml","form_type":"4"}},{"id":747770,"issuer":{"id":8251,"kind":"organization","name":"Cadrenal Therapeutics, Inc.","symbol":"CVKD"},"owners":[{"id":33911,"kind":"person","name":"Pham Quang X","position":1,"cik":"0001405290","reported_name":"Pham Quang X","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2026-06-05T21:26:24.000Z","date":"2026-06-03","kind":"sale","planned":true,"acquired":false,"shares":2323,"price":4.26,"value":9895.98,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of the Issuer's common stock sold by the Reporting Person in accordance with a Rule 10b5-1 trading arrangement adopted by the Reporting Person on September 25, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.18 through $4.39. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":179186,"source":{"system":"sec-edgar","filing":"0001213900-26-065925","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1405290/000121390026065925/ownership.xml","form_type":"4"}},{"id":754489,"issuer":{"id":8251,"kind":"organization","name":"Cadrenal Therapeutics, Inc.","symbol":"CVKD"},"owners":[{"id":33911,"kind":"person","name":"Pham Quang X","position":1,"cik":"0001405290","reported_name":"Pham Quang X","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2026-06-03T00:34:12.000Z","date":"2026-06-02","kind":"sale","planned":true,"acquired":false,"shares":349,"price":4.46,"value":1556.54,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of the Issuer's common stock sold by the Reporting Person in accordance with a Rule 10b5-1 trading arrangement adopted by the Reporting Person on September 25, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.40 through $4.62. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":181509,"source":{"system":"sec-edgar","filing":"0001213900-26-064357","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1405290/000121390026064357/ownership.xml","form_type":"4"}},{"id":754488,"issuer":{"id":8251,"kind":"organization","name":"Cadrenal Therapeutics, Inc.","symbol":"CVKD"},"owners":[{"id":33911,"kind":"person","name":"Pham Quang X","position":1,"cik":"0001405290","reported_name":"Pham Quang X","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2026-06-03T00:34:12.000Z","date":"2026-05-29","kind":"sale","planned":true,"acquired":false,"shares":303,"price":5.01,"value":1518.03,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of the Issuer's common stock sold by the Reporting Person in accordance with a Rule 10b5-1 trading arrangement adopted by the Reporting Person on September 25, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.00 through $5.02. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":181858,"source":{"system":"sec-edgar","filing":"0001213900-26-064357","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1405290/000121390026064357/ownership.xml","form_type":"4"}},{"id":758628,"issuer":{"id":8251,"kind":"organization","name":"Cadrenal Therapeutics, Inc.","symbol":"CVKD"},"owners":[{"id":33911,"kind":"person","name":"Pham Quang X","position":1,"cik":"0001405290","reported_name":"Pham Quang X","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2026-05-29T20:30:26.000Z","date":"2026-05-28","kind":"sale","planned":true,"acquired":false,"shares":2989,"price":4.93,"value":14735.77,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of the Issuer's common stock sold by the Reporting Person in accordance with a Rule 10b5-1 trading arrangement adopted by the Reporting Person on September 25, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.81 through $5.07. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":182161,"source":{"system":"sec-edgar","filing":"0001213900-26-062862","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1405290/000121390026062862/ownership.xml","form_type":"4"}},{"id":758627,"issuer":{"id":8251,"kind":"organization","name":"Cadrenal Therapeutics, Inc.","symbol":"CVKD"},"owners":[{"id":33911,"kind":"person","name":"Pham Quang X","position":1,"cik":"0001405290","reported_name":"Pham Quang X","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2026-05-29T20:30:26.000Z","date":"2026-05-12","kind":"sale","planned":true,"acquired":false,"shares":3298,"price":5.28,"value":17413.44,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of the Issuer's common stock sold by the Reporting Person in accordance with a Rule 10b5-1 trading arrangement adopted by the Reporting Person on September 25, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.07 through $5.535. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The total shares reported as directly owned in Column 5 takes into account subsequent transactions effected by the Reporting Person and reported on a Form 4 filed on May 26, 2026."}],"balance_after":185150,"source":{"system":"sec-edgar","filing":"0001213900-26-062862","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1405290/000121390026062862/ownership.xml","form_type":"4"}},{"id":758626,"issuer":{"id":8251,"kind":"organization","name":"Cadrenal Therapeutics, Inc.","symbol":"CVKD"},"owners":[{"id":33911,"kind":"person","name":"Pham Quang X","position":1,"cik":"0001405290","reported_name":"Pham Quang X","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2026-05-29T20:30:26.000Z","date":"2026-05-11","kind":"sale","planned":true,"acquired":false,"shares":6476,"price":5.76,"value":37301.76,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of the Issuer's common stock sold by the Reporting Person in accordance with a Rule 10b5-1 trading arrangement adopted by the Reporting Person on September 25, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.47 through $6.12. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The total shares reported as directly owned in Column 5 takes into account subsequent transactions effected by the Reporting Person and reported on a Form 4 filed on May 26, 2026."}],"balance_after":188448,"source":{"system":"sec-edgar","filing":"0001213900-26-062862","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1405290/000121390026062862/ownership.xml","form_type":"4"}},{"id":763544,"issuer":{"id":8251,"kind":"organization","name":"Cadrenal Therapeutics, Inc.","symbol":"CVKD"},"owners":[{"id":33911,"kind":"person","name":"Pham Quang X","position":1,"cik":"0001405290","reported_name":"Pham Quang X","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2026-05-27T01:06:53.000Z","date":"2026-05-22","kind":"sale","planned":true,"acquired":false,"shares":1165,"price":5.69,"value":6628.85,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of the Issuer's common stock sold by the Reporting Person in accordance with a Rule 10b5-1 trading arrangement adopted by the Reporting Person on September 25, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.60 through $5.82. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":194924,"source":{"system":"sec-edgar","filing":"0001213900-26-061167","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1405290/000121390026061167/ownership.xml","form_type":"4"}},{"id":1012537,"issuer":{"id":8251,"kind":"organization","name":"Cadrenal Therapeutics, Inc.","symbol":"CVKD"},"owners":[{"id":33911,"kind":"person","name":"Pham Quang X","position":1,"cik":"0001405290","reported_name":"Pham Quang X","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2025-10-28T21:00:02.000Z","date":"2025-10-27","kind":"sale","planned":true,"acquired":false,"shares":1315,"price":13.99,"value":18396.85,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of the Issuer's common stock sold by the Reporting Person in accordance with a Rule 10b5-1 trading arrangement adopted by the Reporting Person on May 9, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.99 through $14.00. The Reporting Person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":196089,"source":{"system":"sec-edgar","filing":"0001213900-25-103146","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1405290/000121390025103146/ownership.xml","form_type":"4"}},{"id":1012536,"issuer":{"id":8251,"kind":"organization","name":"Cadrenal Therapeutics, Inc.","symbol":"CVKD"},"owners":[{"id":33911,"kind":"person","name":"Pham Quang X","position":1,"cik":"0001405290","reported_name":"Pham Quang X","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2025-10-28T21:00:02.000Z","date":"2025-10-24","kind":"sale","planned":true,"acquired":false,"shares":1129,"price":14.03,"value":15839.87,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of the Issuer's common stock sold by the Reporting Person in accordance with a Rule 10b5-1 trading arrangement adopted by the Reporting Person on May 9, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.99 through $14.10. The Reporting Person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":197404,"source":{"system":"sec-edgar","filing":"0001213900-25-103146","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1405290/000121390025103146/ownership.xml","form_type":"4"}},{"id":1019178,"issuer":{"id":8251,"kind":"organization","name":"Cadrenal Therapeutics, Inc.","symbol":"CVKD"},"owners":[{"id":33911,"kind":"person","name":"Pham Quang X","position":1,"cik":"0001405290","reported_name":"Pham Quang X","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2025-10-14T20:05:13.000Z","date":"2025-10-13","kind":"sale","planned":true,"acquired":false,"shares":1800,"price":14.15,"value":25470.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents shares of the Issuer's common stock sold by the Reporting Person in accordance with a Rule 10b5-1 trading arrangement in multiple transactions at prices ranging from $13.99 through $14.33, inclusive, having a weighted average price as shown in column 4 of $14.15. The Reporting Person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":198533,"source":{"system":"sec-edgar","filing":"0001213900-25-098719","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1405290/000121390025098719/ownership.xml","form_type":"4"}},{"id":1019177,"issuer":{"id":8251,"kind":"organization","name":"Cadrenal Therapeutics, Inc.","symbol":"CVKD"},"owners":[{"id":33911,"kind":"person","name":"Pham Quang X","position":1,"cik":"0001405290","reported_name":"Pham Quang X","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2025-10-14T20:05:13.000Z","date":"2025-10-09","kind":"sale","planned":true,"acquired":false,"shares":1800,"price":14.02,"value":25236.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares of the Issuer's common stock sold by the Reporting Person in accordance with a Rule 10b5-1 trading arrangement in multiple transactions at prices ranging from $13.99 through $14.11, inclusive, having a weighted average price as shown in column 4 of $14.02. The Reporting Person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":200333,"source":{"system":"sec-edgar","filing":"0001213900-25-098719","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1405290/000121390025098719/ownership.xml","form_type":"4"}},{"id":1024379,"issuer":{"id":8251,"kind":"organization","name":"Cadrenal Therapeutics, Inc.","symbol":"CVKD"},"owners":[{"id":33911,"kind":"person","name":"Pham Quang X","position":1,"cik":"0001405290","reported_name":"Pham Quang X","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2025-10-04T00:24:26.000Z","date":"2025-10-02","kind":"sale","planned":true,"acquired":false,"shares":500,"price":14.13,"value":7065.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares of the Issuer's common stock sold by the Reporting Person in accordance with a Rule 10b5-1 trading arrangement in multiple transactions at prices ranging from $14.04 through $14.27, inclusive, having a weighted average price as shown in column 4 of $14.13. The Reporting Person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":202133,"source":{"system":"sec-edgar","filing":"0001213900-25-096241","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1405290/000121390025096241/ownership.xml","form_type":"4"}},{"id":1029206,"issuer":{"id":8251,"kind":"organization","name":"Cadrenal Therapeutics, Inc.","symbol":"CVKD"},"owners":[{"id":33911,"kind":"person","name":"Pham Quang X","position":1,"cik":"0001405290","reported_name":"Pham Quang X","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2025-10-01T21:46:56.000Z","date":"2025-10-01","kind":"sale","planned":true,"acquired":false,"shares":881,"price":14.01,"value":12342.81,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents shares of the Issuer's common stock sold by the Reporting Person in accordance with a Rule 10b5-1 trading arrangement in multiple transactions at prices ranging from $13.99 through $14.05, inclusive, having a weighted average price as shown in column 4 of $14.01. The Reporting Person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":202633,"source":{"system":"sec-edgar","filing":"0001213900-25-094803","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1405290/000121390025094803/ownership.xml","form_type":"4"}},{"id":1029205,"issuer":{"id":8251,"kind":"organization","name":"Cadrenal Therapeutics, Inc.","symbol":"CVKD"},"owners":[{"id":33911,"kind":"person","name":"Pham Quang X","position":1,"cik":"0001405290","reported_name":"Pham Quang X","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2025-10-01T21:46:56.000Z","date":"2025-09-29","kind":"sale","planned":true,"acquired":false,"shares":419,"price":14.01,"value":5870.19,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares of the Issuer's common stock sold by the Reporting Person in accordance with a Rule 10b5-1 trading arrangement in multiple transactions at prices ranging from $13.99 through $14.02, inclusive, having a weighted average price as shown in column 4 of $14.01. The Reporting Person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":203514,"source":{"system":"sec-edgar","filing":"0001213900-25-094803","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1405290/000121390025094803/ownership.xml","form_type":"4"}},{"id":1031700,"issuer":{"id":8251,"kind":"organization","name":"Cadrenal Therapeutics, Inc.","symbol":"CVKD"},"owners":[{"id":33911,"kind":"person","name":"Pham Quang X","position":1,"cik":"0001405290","reported_name":"Pham Quang X","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2025-09-27T00:35:26.000Z","date":"2025-09-25","kind":"sale","planned":true,"acquired":false,"shares":6790,"price":14.09,"value":95671.1,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents shares of the Issuer's common stock sold by the Reporting Person in multiple transactions at prices ranging from $13.99 through $14.14, inclusive, having a weighted average price as shown in column 4 of $14.09. The Reporting Person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":203933,"source":{"system":"sec-edgar","filing":"0001213900-25-092557","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1405290/000121390025092557/ownership.xml","form_type":"4"}},{"id":1031699,"issuer":{"id":8251,"kind":"organization","name":"Cadrenal Therapeutics, Inc.","symbol":"CVKD"},"owners":[{"id":33911,"kind":"person","name":"Pham Quang X","position":1,"cik":"0001405290","reported_name":"Pham Quang X","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2025-09-27T00:35:26.000Z","date":"2025-09-24","kind":"sale","planned":true,"acquired":false,"shares":2581,"price":13.99,"value":36108.19,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares of the Issuer's common stock sold by the Reporting Person in multiple transactions, at a price of $13.99 for each transaction."}],"balance_after":210723,"source":{"system":"sec-edgar","filing":"0001213900-25-092557","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1405290/000121390025092557/ownership.xml","form_type":"4"}},{"id":1052793,"issuer":{"id":8251,"kind":"organization","name":"Cadrenal Therapeutics, Inc.","symbol":"CVKD"},"owners":[{"id":33911,"kind":"person","name":"Pham Quang X","position":1,"cik":"0001405290","reported_name":"Pham Quang X","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2025-08-30T00:34:51.000Z","date":"2025-08-28","kind":"sale","planned":true,"acquired":false,"shares":1193,"price":13.99,"value":16690.07,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Represents shares of the Issuer's common stock sold on the Transaction Date by the Reporting Person in multiple transactions at prices ranging from $13.99 through $14.04, inclusive, having a weighted average price as shown in column 4 of $13.99. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":213304,"source":{"system":"sec-edgar","filing":"0001213900-25-082819","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1405290/000121390025082819/ownership.xml","form_type":"4"}},{"id":1052792,"issuer":{"id":8251,"kind":"organization","name":"Cadrenal Therapeutics, Inc.","symbol":"CVKD"},"owners":[{"id":33911,"kind":"person","name":"Pham Quang X","position":1,"cik":"0001405290","reported_name":"Pham Quang X","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2025-08-30T00:34:51.000Z","date":"2025-08-27","kind":"sale","planned":true,"acquired":false,"shares":3836,"price":13.99,"value":53665.64,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares of the Issuer's common stock sold on the Transaction Date by the Reporting Person in multiple transactions at prices ranging from $13.99 through $14.03, inclusive, having a weighted average price as shown in column 4 of $13.99. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."}],"balance_after":214497,"source":{"system":"sec-edgar","filing":"0001213900-25-082819","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1405290/000121390025082819/ownership.xml","form_type":"4"}},{"id":1193314,"issuer":{"id":8251,"kind":"organization","name":"Cadrenal Therapeutics, Inc.","symbol":"CVKD"},"owners":[{"id":33911,"kind":"person","name":"Pham Quang X","position":1,"cik":"0001405290","reported_name":"Pham Quang X","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Stock Options","published_at":"2025-03-25T00:38:14.000Z","date":"2025-01-23","kind":"grant","planned":false,"acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"This amendment to Form 4 is being filed to correct the exercise price and the expiration date of the stock option, which were incorrectly reported on the original Form 4 filed by the Reporting Person on January 24, 2025 (the \"Original Form 4\"). The exercise price of the stock option is equal to 100% of the fair market value of the Issuer's common stock on the effective date of the grant and the stock option expires ten years from the date of issuance. The stock option vests according to the vesting schedule as previously reported on the Original Form 4."}],"balance_after":65000,"derivative":{"exercise_price":19.79,"exercise_date":"2026-02-01","expiration_date":"2035-01-22","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001013762-25-001779","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1405290/000101376225001779/ownership.xml","form_type":"4/A","original_submission_date":"2025-01-24"}},{"id":1295496,"issuer":{"id":8251,"kind":"organization","name":"Cadrenal Therapeutics, Inc.","symbol":"CVKD"},"owners":[{"id":33911,"kind":"person","name":"Pham Quang X","position":1,"cik":"0001405290","reported_name":"Pham Quang X","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Stock Options","published_at":"2025-01-24T23:10:17.000Z","date":"2025-01-23","kind":"grant","planned":false,"acquired":true,"shares":65000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of options to purchase 65,000 shares of common stock, which shall vest 1/4 on February 1, 2026 and thereafter pro rata on a monthly basis over three years, subject to the Reporting Person's continued service to the Issuer through each vesting date, having an exercise price equal to 110% of the fair market value of the Issuer's common stock on the effective date of the grant."}],"balance_after":65000,"derivative":{"exercise_price":21.769,"exercise_date":"2026-02-01","expiration_date":"2030-01-22","underlying":"Common Stock","underlying_shares":65000},"source":{"system":"sec-edgar","filing":"0001213900-25-006630","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1405290/000121390025006630/ownership.xml","form_type":"4"}},{"id":1543652,"issuer":{"id":8251,"kind":"organization","name":"Cadrenal Therapeutics, Inc.","symbol":"CVKD"},"owners":[{"id":33911,"kind":"person","name":"Pham Quang X","position":1,"cik":"0001405290","reported_name":"Pham Quang X","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2024-04-10T21:30:18.000Z","date":"2024-04-10","kind":"gift","planned":false,"acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On April 10, 2024 Quang Pham transferred an aggregate of 50,000 shares of common stock to a non-for-profit organization, as a gift for no value received, pursuant to a written agreement with the organizations signed by a representative of such organization and Mr. Pham."}],"balance_after":3275000,"source":{"system":"sec-edgar","filing":"0001213900-24-031923","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1405290/000121390024031923/ownership.xml","form_type":"4"}},{"id":1649005,"issuer":{"id":8251,"kind":"organization","name":"Cadrenal Therapeutics, Inc.","symbol":"CVKD"},"owners":[{"id":33911,"kind":"person","name":"Pham Quang X","position":1,"cik":"0001405290","reported_name":"Pham Quang X","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2024-02-13T02:41:26.000Z","date":"2023-10-23","kind":"gift","planned":false,"acquired":false,"shares":85000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On October 23, 2023, Quang Pham transferred an aggregate of 85,000 shares of common stock to three non-for-profit organizations, as gifts for no value received, pursuant to a written agreement with each of the three organizations signed by a representative of each such organization and Mr. Pham."}],"balance_after":3325000,"source":{"system":"sec-edgar","filing":"0001213900-24-012837","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1405290/000121390024012837/ownership.xml","form_type":"4"}},{"id":1675103,"issuer":{"id":8251,"kind":"organization","name":"Cadrenal Therapeutics, Inc.","symbol":"CVKD"},"owners":[{"id":33911,"kind":"person","name":"Pham Quang X","position":1,"cik":"0001405290","reported_name":"Pham Quang X","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options","published_at":"2024-01-20T00:40:20.000Z","date":"2024-01-18","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"These options vest 25% on February 1, 2025 and thereafter pro rata on a monthly basis for the next 36 months."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options vest 25% on February 1, 2025 and thereafter pro rata on a monthly basis for the next 36 months."}],"balance_after":150000,"derivative":{"exercise_price":0.94,"expiration_date":"2034-01-17","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001213900-24-005001","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1405290/000121390024005001/ownership.xml","form_type":"4"}},{"id":1786943,"issuer":{"id":8251,"kind":"organization","name":"Cadrenal Therapeutics, Inc.","symbol":"CVKD"},"owners":[{"id":33911,"kind":"person","name":"Pham Quang X","position":1,"cik":"0001405290","reported_name":"Pham Quang X","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2023-09-06T19:28:01.000Z","date":"2023-09-05","kind":"purchase","planned":false,"acquired":true,"shares":20000,"price":0.8994,"value":17988.0,"ownership":{"direct":true},"balance_after":3410000,"source":{"system":"sec-edgar","filing":"0001213900-23-074336","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1405290/000121390023074336/ownership.xml","form_type":"4"}},{"id":1786942,"issuer":{"id":8251,"kind":"organization","name":"Cadrenal Therapeutics, Inc.","symbol":"CVKD"},"owners":[{"id":33911,"kind":"person","name":"Pham Quang X","position":1,"cik":"0001405290","reported_name":"Pham Quang X","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2023-09-06T19:28:01.000Z","date":"2023-09-05","kind":"purchase","planned":false,"acquired":true,"shares":20000,"price":0.91,"value":18200.0,"ownership":{"direct":true},"balance_after":3390000,"source":{"system":"sec-edgar","filing":"0001213900-23-074336","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1405290/000121390023074336/ownership.xml","form_type":"4"}},{"id":1789026,"issuer":{"id":8251,"kind":"organization","name":"Cadrenal Therapeutics, Inc.","symbol":"CVKD"},"owners":[{"id":33911,"kind":"person","name":"Pham Quang X","position":1,"cik":"0001405290","reported_name":"Pham Quang X","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2023-09-05T10:05:15.000Z","date":"2023-09-01","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":0.8433,"value":8433.0,"ownership":{"direct":true},"balance_after":3370000,"source":{"system":"sec-edgar","filing":"0001213900-23-073551","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1405290/000121390023073551/ownership.xml","form_type":"4"}},{"id":1789025,"issuer":{"id":8251,"kind":"organization","name":"Cadrenal Therapeutics, Inc.","symbol":"CVKD"},"owners":[{"id":33911,"kind":"person","name":"Pham Quang X","position":1,"cik":"0001405290","reported_name":"Pham Quang X","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2023-09-05T10:05:15.000Z","date":"2023-09-01","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":0.9168,"value":9168.0,"ownership":{"direct":true},"balance_after":3360000,"source":{"system":"sec-edgar","filing":"0001213900-23-073551","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1405290/000121390023073551/ownership.xml","form_type":"4"}},{"id":1789024,"issuer":{"id":8251,"kind":"organization","name":"Cadrenal Therapeutics, Inc.","symbol":"CVKD"},"owners":[{"id":33911,"kind":"person","name":"Pham Quang X","position":1,"cik":"0001405290","reported_name":"Pham Quang X","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2023-09-05T10:05:15.000Z","date":"2023-09-01","kind":"purchase","planned":false,"acquired":true,"shares":20000,"price":0.9222,"value":18444.0,"ownership":{"direct":true},"balance_after":3350000,"source":{"system":"sec-edgar","filing":"0001213900-23-073551","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1405290/000121390023073551/ownership.xml","form_type":"4"}},{"id":1789023,"issuer":{"id":8251,"kind":"organization","name":"Cadrenal Therapeutics, Inc.","symbol":"CVKD"},"owners":[{"id":33911,"kind":"person","name":"Pham Quang X","position":1,"cik":"0001405290","reported_name":"Pham Quang X","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2023-09-05T10:05:15.000Z","date":"2023-09-01","kind":"purchase","planned":false,"acquired":true,"shares":20000,"price":0.9291,"value":18582.0,"ownership":{"direct":true},"balance_after":3330000,"source":{"system":"sec-edgar","filing":"0001213900-23-073551","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1405290/000121390023073551/ownership.xml","form_type":"4"}},{"id":1789022,"issuer":{"id":8251,"kind":"organization","name":"Cadrenal Therapeutics, Inc.","symbol":"CVKD"},"owners":[{"id":33911,"kind":"person","name":"Pham Quang X","position":1,"cik":"0001405290","reported_name":"Pham Quang X","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2023-09-05T10:05:15.000Z","date":"2023-09-01","kind":"purchase","planned":false,"acquired":true,"shares":10000,"price":0.9318,"value":9318.0,"ownership":{"direct":true},"balance_after":3310000,"source":{"system":"sec-edgar","filing":"0001213900-23-073551","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1405290/000121390023073551/ownership.xml","form_type":"4"}},{"id":2019790,"issuer":{"id":8251,"kind":"organization","name":"Cadrenal Therapeutics, Inc.","symbol":"CVKD"},"owners":[{"id":33911,"kind":"person","name":"Pham Quang X","position":1,"cik":"0001405290","reported_name":"Pham Quang X","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"CEO and Chairman"}}],"security":"Common Stock","published_at":"2023-02-13T14:00:39.000Z","date":"2023-02-10","kind":"grant","acquired":true,"shares":25000,"price":1.94,"value":48500.0,"ownership":{"direct":true},"balance_after":3300000,"source":{"system":"sec-edgar","filing":"0001213900-23-010504","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1405290/000121390023010504/ownership.xml","form_type":"4"}}]}